ArticleCytoJournal2026
Malignant melanoma of the female genital tract diagnosed by cervicovaginal smear: A rare case from the Middle East.
Article in CytoJournal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant melanoma is a rare form of cancer in the Middle East, and its occurrence, particularly in the female genital tract, is exceptionally uncommon. These tumors often present diagnostic challenges due to their rarity and variable cytomorphological features. We report the case of a 61-year-old postmenopausal woman from a rural region who presented with vaginal bleeding. A routine Papanicolaou (Pap) smear revealed atypical pigmented malignant cells, raising suspicion for melanoma. Histopathological examination of a vaginal wall biopsy, supported by immunohistochemical staining, confirmed the diagnosis of malignant melanoma. The patient underwent total vaginectomy with labia minora resection. Post-operative positron emission tomography showed no residual or metastatic disease. She is currently receiving adjuvant nivolumab and is doing well. To the best of our knowledge, melanoma diagnosed through cervicovaginal Pap smear has been rarely documented in a Middle Eastern woman. This case underscores the critical role of cytological screening and the importance of a broad differential diagnosis for detecting rare malignancies, even in low-incidence regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.